Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

PUBLICATION DATE

6 results
Display

Three-dimensional surgical simulation for facial asymmetry: soft tissue-, skeleton-, and occlusion-based planning

Kwon TG

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Conservative management (marsupialization) of unicystic ameloblastoma: literature review and a case report

Kim J, Nam E, Yoon S

BACKGROUND: In this study, we present a case of unicystic ameloblastoma (UA) treated by marsupialization followed by surgical enucleation as a conservative approach. UA is a rare, benign, less aggressive,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Extraction socket sealing using palatal gingival grafts and resorbable collagen membranes

Kim SY, Kim YK, Kim HS, Yun PY, Kim SG, Choi YH

BACKGROUND: Socket sealing surgery is performed for the preservation of the form and volume of the soft tissue by covering the resulting socket with autogenous soft tissue graft or membrane...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Analysis of the outcome of young age tongue squamous cell carcinoma

Jeon JH, Kim MG, Park JY, Lee JH, Kim MJ, Myoung H, Choi SW

BACKGROUND: The incidence of tongue squamous cell carcinoma (TSCC) in young patients has recently increased, and these TSCCs are believed to be etiologically distinct from those in older patients, who...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Evaluation of bone healing using rhBMP-2 soaked hydroxyapatite in ridge augmentation: a prospective observational study

Kim HS, Park JC, Yun PY, Kim YK

BACKGROUND: The goal of this study is to evaluate complication and effectiveness of alveolar ridge augmentations using a hydroxyapatite-based alloplastic bony substitute with rhBMP-2. METHODS: A total of 10 patients (4...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Hyperpigmentation of the hard palate mucosa in a patient with chronic myeloid leukaemia taking imatinib

Bombeccari GP, Garagiola , Pallotti F, Rossi M, Porrini M, Giannì AB, Spadari F

BACKGROUND: Imatinib mesylate is an inhibitor of the tyrosine kinase Bcr–Abl and a first-line treatment for Philadelphia chromosome-positive chronic myeloid leukaemia (CML). Dermatological side effects include superficial oedema, pustular eruption,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr